SRC and nonpapillary renal cell carcinoma: This finding holds clinical significance, as ccRCC patients with high SRC expression exhibited a median overall survival of 52 months (95% confidence interval [CI] 45–59 months), which was significantly shorter than the 117-month survival observed in patients with intermediate SRC levels (p = 6·10−8) (Figure 1E).